RxDoctor Payments Data

Dien Do, NP

Gerontology · Phoenix, AZNPI 1609326289

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,149 of the $2,740 with a category attached, or 78.4%. 18 manufacturers reported payments, led by Spinal Simplicity, LLC at 25.1% of the total.

$2,740in general payments, 2019–2025

Across 97 payments — averaging $28.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$686
  • Abbott$510
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$248
  • Medtronic$248
  • Nevro Corp.$198
  • Boston Scientific$189
  • plus $661 from 12 others

What the payments were for

  • Travel & lodging$59122%
  • Food & beverage$2,14978%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,740 in reported general payments places this provider in the 75th percentile of 99 gerontology providers in Arizona.

See all gerontology providers in Arizona

Medicare billing

Part B allowed, 2024
$143,316
Medicare patients
397
Services billed
1,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,038$30,804
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen999$23,980
OxycontinOxycodone Hcl38$22,587
Oxycodone Hcl917$16,968
Xtampza ErOxycodone Myristate36$13,955
Gabapentin750$12,484
Buprenorphine51$12,231
Pregabalin439$10,686
Morphine Sulfate ErMorphine Sulfate207$8,896
MovantikNaloxegol Oxalate13$7,956
Tizanidine Hcl439$3,968
Tramadol Hcl437$3,866
Lidocaine36$3,581
Fentanyl33$2,800
Celecoxib136$2,653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$14$14,501142 claims
Collegium Pharmaceutical, Inc.Xtampza Er$176$13,95536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 99 gerontology providers in Arizona.

Other gerontology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →